Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

24. November 2025 09:00 ET | Quelle: JenaValve Technology, Inc.

JenaValve Announces New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves

IRVINE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced results from an...
17. November 2025 09:00 ET | Quelle: JenaValve Technology, Inc.

JenaValve Announces 1,000th Case with the Trilogy™ Transcatheter Heart Valve (THV) System

IRVINE, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced the completion of its...
10. November 2025 09:00 ET | Quelle: JenaValve Technology, Inc.

JenaValve‘s Trilogy™ System Featured in Live Procedure at TCT 2025

IRVINE, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the...
10. September 2025 08:00 ET | Quelle: JenaValve Technology, Inc.

JenaValve Announced ESC Guidelines Recognize TAVI as Class IIb Recommendation for Aortic Regurgitation

IRVINE, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that the newly...
06. August 2025 14:17 ET | Quelle: JenaValve Technology, Inc.

JenaValve Responds to FTC’s Action Against Proposed Edwards Lifesciences Acquisition

IRVINE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology announced today that the U.S. Federal Trade Commission (FTC) moved to block the company’s proposed acquisition by Edwards...
14. Juli 2025 08:00 ET | Quelle: JenaValve Technology, Inc.

JenaValve Announces First Patient Enrolled in ARTIST Randomized Controlled Trial (RCT) Evaluating the Trilogy™ System in Aortic Regurgitation (AR)

IRVINE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that patient...
07. Juli 2025 08:00 ET | Quelle: JenaValve Technology, Inc.

JenaValve's Trilogy™ THV System Procedures Live Broadcast at New York Valves 2025

IRVINE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the...
31. März 2025 09:00 ET | Quelle: JenaValve Technology, Inc.

JenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial

IRVINE, Calif. and CHICAGO, March 31, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, presented results from...
16. Dezember 2024 09:00 ET | Quelle: JenaValve Technology, Inc.

JenaValve Announces First Case for Inclusion in JENA-VAD Registry

IRVINE, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced the completion of the...
12. November 2024 09:00 ET | Quelle: JenaValve Technology, Inc.

JenaValve Presents ALIGN-AR 2-Year Follow-Up Data at TCT 2024 and Announces Commencement of ARTIST Randomized Controlled Trial (RCT)

IRVINE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, showcased 2-year follow up data from...

Nächste Seite